Research & Innovation
Publications
Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma.
PMU Authors
Martina Meßner, Maximilian Alexander Ardelt, Petra Huber-Cantonati, Johanna Pachmayr
All Authors
Martina Meßner, Sabine Schmitt, Maximilian Alexander Ardelt, Thomas Fröhlich, Martin Müller, Helmut Pein, Petra Huber-Cantonati, Carina Ortler, Lars M Koenig, Lena Zobel, Andreas Koeberle, Georg J Arnold, Simon Rothenfußer, Alexandra K Kiemer, Alexander L Gerbes, Hans Zischka, Angelika M Vollmar, Johanna Pachmayr
Journal association
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
Abstract
Keywords
INHIBITION, THERAPY, RECEPTOR, OXIDATIVE-PHOSPHORYLATION, PROLIFERATION, CANCER-CELLS, TRANSLATION, ANTITUMOR-ACTIVITY, MITOCHONDRIAL BIOGENESIS, MITOPHAGY